These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25886742)

  • 1. TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells.
    Folgiero V; Cifaldi L; Li Pira G; Goffredo BM; Vinti L; Locatelli F
    J Hematol Oncol; 2015 Apr; 8():36. PubMed ID: 25886742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
    Caforio M; Sorino C; Caruana I; Weber G; Camera A; Cifaldi L; De Angelis B; Del Bufalo F; Vitale A; Goffredo BM; De Vito R; Fruci D; Quintarelli C; Fanciulli M; Locatelli F; Folgiero V
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.
    Gleason MK; Lenvik TR; McCullar V; Felices M; O'Brien MS; Cooley SA; Verneris MR; Cichocki F; Holman CJ; Panoskaltsis-Mortari A; Niki T; Hirashima M; Blazar BR; Miller JS
    Blood; 2012 Mar; 119(13):3064-72. PubMed ID: 22323453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.
    Folgiero V; Goffredo BM; Filippini P; Masetti R; Bonanno G; Caruso R; Bertaina V; Mastronuzzi A; Gaspari S; Zecca M; Torelli GF; Testi AM; Pession A; Locatelli F; Rutella S
    Oncotarget; 2014 Apr; 5(8):2052-64. PubMed ID: 24903009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin.
    Nasri F; Sadeghi F; Behranvand N; Samei A; Bolouri MR; Azari T; Abdollahi E; Ghazizadeh F; Motevalian M; Hassan ZM; Falak R
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):602-611. PubMed ID: 33463129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells.
    Gonçalves Silva I; Yasinska IM; Sakhnevych SS; Fiedler W; Wellbrock J; Bardelli M; Varani L; Hussain R; Siligardi G; Ceccone G; Berger SM; Ushkaryov YA; Gibbs BF; Fasler-Kan E; Sumbayev VV
    EBioMedicine; 2017 Aug; 22():44-57. PubMed ID: 28750861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
    Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
    Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression].
    Kikushige Y
    Rinsho Ketsueki; 2016 Apr; 57(4):412-6. PubMed ID: 27169443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway.
    Sun J; Yang M; Ban Y; Gao W; Song B; Wang Y; Zhang Y; Shao Q; Kong B; Qu X
    PLoS One; 2016; 11(1):e0147186. PubMed ID: 26789128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.
    Cheng YQ; Ren JP; Zhao J; Wang JM; Zhou Y; Li GY; Moorman JP; Yao ZQ
    Immunology; 2015 Aug; 145(4):485-97. PubMed ID: 25772938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells.
    Gonçalves Silva I; Gibbs BF; Bardelli M; Varani L; Sumbayev VV
    Oncotarget; 2015 Oct; 6(32):33823-33. PubMed ID: 26413815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia.
    Stringaris K; Sekine T; Khoder A; Alsuliman A; Razzaghi B; Sargeant R; Pavlu J; Brisley G; de Lavallade H; Sarvaria A; Marin D; Mielke S; Apperley JF; Shpall EJ; Barrett AJ; Rezvani K
    Haematologica; 2014 May; 99(5):836-47. PubMed ID: 24488563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.
    Corradi G; Bassani B; Simonetti G; Sangaletti S; Vadakekolathu J; Fontana MC; Pazzaglia M; Gulino A; Tripodo C; Cristiano G; Bandini L; Ottaviani E; Ocadlikova D; Piccioli M; Martinelli G; Colombo MP; Rutella S; Cavo M; Ciciarello M; Curti A
    Clin Cancer Res; 2022 Jul; 28(14):3141-3155. PubMed ID: 35349670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape].
    Tang XQ; Zhao ZG; Wang HX; Li QB; Lü J; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):539-42. PubMed ID: 16800938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion.
    Yıldırım C
    Mol Biol Rep; 2024 Apr; 51(1):571. PubMed ID: 38662155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion.
    Khaznadar Z; Boissel N; Agaugué S; Henry G; Cheok M; Vignon M; Geromin D; Cayuela JM; Castaigne S; Pautas C; Raffoux E; Lachuer J; Sigaux F; Preudhomme C; Dombret H; Dulphy N; Toubert A
    J Immunol; 2015 Sep; 195(6):2580-90. PubMed ID: 26246143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
    Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
    Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection.
    Jost S; Moreno-Nieves UY; Garcia-Beltran WF; Rands K; Reardon J; Toth I; Piechocka-Trocha A; Altfeld M; Addo MM
    Retrovirology; 2013 Jul; 10():74. PubMed ID: 23866914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell immune escape in acute myeloid leukemia.
    Lion E; Willemen Y; Berneman ZN; Van Tendeloo VF; Smits EL
    Leukemia; 2012 Sep; 26(9):2019-26. PubMed ID: 22446501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.
    Zhou Q; Munger ME; Veenstra RG; Weigel BJ; Hirashima M; Munn DH; Murphy WJ; Azuma M; Anderson AC; Kuchroo VK; Blazar BR
    Blood; 2011 Apr; 117(17):4501-10. PubMed ID: 21385853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.